|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 513/04 | |
| A61K 31/444 | |||
| A61P 7/02 | |||
| C07B 61/00 |
| (11) | Patento numeris | 3109251 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15752746.6 |
| Europos patento paraiškos padavimo data | 2015-02-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2015/054001 |
| Data | 2015-02-13 |
| (87) | Numeris | WO 2015/125710 |
| Data | 2015-08-27 |
| (30) | Numeris | Data | Šalis |
| 2014028266 | 2014-02-18 | JP |
| (72) |
UEDA, Tsuyoshi, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426,
JP
|
| (54) | METHOD FOR PRODUCING INHIBITOR OF ACTIVATED BLOOD COAGULATION FACTOR X (FXA) |
| METHOD FOR PRODUCING INHIBITOR OF ACTIVATED BLOOD COAGULATION FACTOR X (FXA) |